Community Orientation Webinar
If you were not able to attend this exciting webinar, watch the recording above.
The Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on June 7, 2024, will be an exciting opportunity to inform the U.S. Food and Drug Administration (FDA) and other stakeholders about the patient and caregiver perspectives on living with dermatomyositis.
In this Community Orientation Webinar, you will learn how dermatomyositis patients can participate virtually in this first-ever meeting for Adult Dermatomyositis. James Valentine and Larry Bauer of Hyman Phelps McNamara will help you understand the drug development process and the role of the FDA and what will happen at the meeting on June 7. More importantly, they will discuss how YOU can participate that day through polling questions, call-in comments, and written submissions on your journey with dermatomyositis.
DON’T MISS THIS OPPORTUNITY TO MAKE SURE THE COLLECTIVE VOICE OF HUNDREDS OF PATIENTS ARE HEARD!
Be sure to visit the dedicated website for this project for updates and more. Click the button below to visit the site.
